Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality

Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality

In recent years, considerable advances concerning therapeutic strategies in patients with metastatic cancer have been achieved. Particularly in renal cell cancer (RCC) and advanced stage non-small cell lung cancer (NSCLC), immune-activating and antiangiogenic (AA) drugs (i.e., checkpoint antibodies...

Full description

Bibliographic Details
Main Authors: Andreas Pircher, Dominik Wolf, Axel Heidenreich, Wolfgang Hilbe, Renate Pichler, Isabel Heidegger
Format: Article
Language:English
Published: MDPI AG 2017-10-01
Series:International Journal of Molecular Sciences
Subjects:
angiogenesis
immunotherapy
checkpoint inhibition
VEGF inhibition
renal cell cancer
non-small cell lung cancer
Online Access:https://www.mdpi.com/1422-0067/18/11/2291

Similar Items

Similar Items